ClinConnect ClinConnect Logo
Search / Trial NCT06817122

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Launched by UNIVERSITY OF WASHINGTON · Feb 7, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Let'S Talk Tech Shared Decision Aid Technology Decision Making Advance Care Planning Dyadic Intervention

ClinConnect Summary

The "Let's Talk Tech" trial is studying a new tool designed to help families make decisions about using technology to support people with memory difficulties, like those with mild dementia or mild cognitive impairment (MCI). The goal is to see if this tool can help families feel more prepared and confident when choosing technologies that can assist in caring for their loved ones at home. Participants will either use the "Let's Talk Tech" web application with a support person or receive usual care without any intervention. They will also complete three surveys over a few months to share their experiences and feelings about the tool.

To take part in this study, participants must be 55 or older and have mild dementia or MCI. They also need to understand and speak English. The support person, known as the co-participant, must be at least 18 years old and is someone the patient identifies as their primary support. There are no specific health exclusions for this trial. If you or a loved one fit these criteria, you could play an important role in helping researchers understand how to improve decision-making about technology in caregiving.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for Patients:
  • have mild cognitive impairment (MCI) or mild dementia
  • age 55 or older
  • able to understand and speak English
  • Inclusion Criteria for Co-participants:
  • be identified by the patient as their primary support person
  • age 18 or older
  • able to understand and speak English
  • able to complete LTT together with their study partner at the same time
  • Exclusion Criteria:
  • None

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Clara Berridge, PhD

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported